Data Suggest Antibiotics, PPIs Blunt Anti-PD Activity

<![CDATA[]]>(MedPage Today) — Survival in advanced non-small cell lung cancer (NSCLC) declined significantly in patients treated with antibiotics or a proton pump inhibitor (PPI) at the same time they received a PD-L1 inhibitor, pooled data from two randomized…

Source link

Related posts

CME Exam 3: Risk of Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease


A Fluttering Blue Hue is Tough to Subdue


Bad mutants in IBD


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World